By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
Vivek Ramaswamy's Urovant Sciences Taps Former AVANIR (AVNR) Exec As Its New CEO 9/18/2017 6:51:32 AM
AVANIR (AVNR) Initiates Phase II Study To Evaluate AVP-786 For Treatment Of Neurobehavioral Disinhibition Associated With Traumatic Brain Injury 6/7/2017 7:19:26 AM
AVANIR (AVNR) Appoints Richard Malamut, MD, As Senior Vice President, Research & Development, And Chief Medical Officer 11/29/2016 10:37:53 AM
AVANIR (AVNR) To Present Data On ONZETRA Xsail At American Headache Society (AHS) 2016 Annual Scientific Meeting 6/10/2016 10:10:42 AM
AVANIR (AVNR) Release: NUEDEXTA Effective For Pseudobulbar Affect (PBA) In Patients With Alzheimer's Disease And Other Dementias, Stroke And Traumatic Brain Injury 6/9/2016 9:47:04 AM
AVANIR (AVNR) Announces U.S. Launch And Availability Of ONZETRA Xsail For The Acute Treatment Of Migraine In Adults 5/16/2016 7:23:36 AM
AVANIR (AVNR) To Present Data On NUEDEXTA And ONZETRA Xsail At American Academy of Neurology 2016 Annual Meeting 4/18/2016 8:41:07 AM
FDA Approves AVANIR (AVNR) New Migraine Treatment With Unique Inhalant Delivery System 1/29/2016 6:01:52 AM
AVANIR (AVNR) Taps New CEO with Commitment to Creating A Multi-Product CNS Company 1/26/2016 10:52:40 AM
AVANIR (AVNR) Names a New CEO 1/20/2016 6:43:04 AM